| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCNB2
|
cyclin B2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CDC25B
|
cell division cycle 25B
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
DNM1
|
dynamin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL2
|
interleukin 2
|
|
IL6
|
interleukin 6
|
|
INSR
|
insulin receptor
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KDR
|
kinase insert domain receptor
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NGFR
|
nerve growth factor receptor
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
RXRG
|
retinoid X receptor, gamma
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SYK
|
spleen tyrosine kinase
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|